---
$id: https://graph.org.ai/products/commodity/51372117
$type: Product
source: UNSPSC
code: "51372117"
title: "Dihydrocodeine bitartrate"
class: "51372100"
classTitle: "Controlled substance analgesic morphine derivatives"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dihydrocodeine bitartrate

**UNSPSC Code**: 51372117
**Class**: [Controlled substance analgesic morphine derivatives](Controlled substance analgesic morphine derivatives.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid with the molecular formula C18H23NO3.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8LXS95BSA9, chemically known as 7, 8-dihydrocodeine but more generally known as dihydrocodeine bitartrate, which bears US NIH Compound Identifier 3063. European Medicines Agency schedules Dihydrocodeine bitartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01704MIG. Most nations, for tariff and trade purposes, schedule dihydrocodeine bitartrate under HS 29391100 and SITC 54141. As of Q4 2014, DIHYDROCODEINE BITARTRATE remains US FDA's Preferred Term for this commodity. Dihydrocodeine bitartrate bears US NLM identifiers UMLS ID C0355564 and NCI Concept Code C47490. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](CC[C@H]3[C@H]1C5)O)OC.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O.

